Chronic lung allograft dysfunction and its main phenotypes, bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS), are major causes of mortality after lung transplantation (LT). RAS and early-onset BOS, developing within 3 years after LT, are associated with particularly inferior clinical outcomes. Prediction models for early-onset BOS and RAS have not been previously described
The impact of allograft injury time of onset on the risk of chronic lung allograft dysfunction (CLAD...
Lung transplantation is the treatment of choice for patients with end-stage lung disease. However, l...
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, cau...
Background: Chronic lung allograft dysfunction and its main phenotypes, bronchiolitis obliterans syn...
BACKGROUND Chronic lung allograft dysfunction and its main phenotypes, bronchiolitis obliterans synd...
Chronic lung allograft dysfunction and its main phenotypes, bronchiolitis obliterans syndrome (BOS) ...
AbstractBronchiolitis obliterans syndrome (BOS) is a significant post-transplant complication with l...
BACKGROUND: Chronic lung allograft dysfunction (CLAD) is the main factor limiting long-term survival...
Chronic lung allograft dysfunction is a heterogeneous entity limiting long-term survival after lung ...
AbstractObjective: This study identifies specific clinical and immunologic factors in lung transplan...
Chronic lung allograft dysfunction (CLAD) remains a major hurdle limiting long-term survival post lu...
The main limitation for overall survival after lung transplantation (LTx) is the development of chro...
ObjectivesIn 2005, the time-based waiting list for lung transplantation was replaced by an illness/b...
Background: Primary graft dysfunction (PGD) is an early complication of lung transplantation associ...
Bronchiolitis obliterans syndrome (BOS) is the main and late chronic complication after lung transpl...
The impact of allograft injury time of onset on the risk of chronic lung allograft dysfunction (CLAD...
Lung transplantation is the treatment of choice for patients with end-stage lung disease. However, l...
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, cau...
Background: Chronic lung allograft dysfunction and its main phenotypes, bronchiolitis obliterans syn...
BACKGROUND Chronic lung allograft dysfunction and its main phenotypes, bronchiolitis obliterans synd...
Chronic lung allograft dysfunction and its main phenotypes, bronchiolitis obliterans syndrome (BOS) ...
AbstractBronchiolitis obliterans syndrome (BOS) is a significant post-transplant complication with l...
BACKGROUND: Chronic lung allograft dysfunction (CLAD) is the main factor limiting long-term survival...
Chronic lung allograft dysfunction is a heterogeneous entity limiting long-term survival after lung ...
AbstractObjective: This study identifies specific clinical and immunologic factors in lung transplan...
Chronic lung allograft dysfunction (CLAD) remains a major hurdle limiting long-term survival post lu...
The main limitation for overall survival after lung transplantation (LTx) is the development of chro...
ObjectivesIn 2005, the time-based waiting list for lung transplantation was replaced by an illness/b...
Background: Primary graft dysfunction (PGD) is an early complication of lung transplantation associ...
Bronchiolitis obliterans syndrome (BOS) is the main and late chronic complication after lung transpl...
The impact of allograft injury time of onset on the risk of chronic lung allograft dysfunction (CLAD...
Lung transplantation is the treatment of choice for patients with end-stage lung disease. However, l...
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, cau...